Global Combination Antibody Therapy Market Research Report 2023

Report ID: 1993998 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Combination Antibody Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Chemotherapy Antibody
        1.2.3 Antibody
        1.2.4 Conjugated Antibodies
        1.2.5 Bispecific Antibodies
    1.3 Market by Application
        1.3.1 Global Combination Antibody Therapy Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospitals
        1.3.3 Cancer Research Institutes
        1.3.4 Clinics
        1.3.5 ASCs
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Combination Antibody Therapy Market Perspective (2018-2029)
    2.2 Combination Antibody Therapy Growth Trends by Region
        2.2.1 Global Combination Antibody Therapy Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Combination Antibody Therapy Historic Market Size by Region (2018-2023)
        2.2.3 Combination Antibody Therapy Forecasted Market Size by Region (2024-2029)
    2.3 Combination Antibody Therapy Market Dynamics
        2.3.1 Combination Antibody Therapy Industry Trends
        2.3.2 Combination Antibody Therapy Market Drivers
        2.3.3 Combination Antibody Therapy Market Challenges
        2.3.4 Combination Antibody Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Combination Antibody Therapy Players by Revenue
        3.1.1 Global Top Combination Antibody Therapy Players by Revenue (2018-2023)
        3.1.2 Global Combination Antibody Therapy Revenue Market Share by Players (2018-2023)
    3.2 Global Combination Antibody Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Combination Antibody Therapy Revenue
    3.4 Global Combination Antibody Therapy Market Concentration Ratio
        3.4.1 Global Combination Antibody Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Combination Antibody Therapy Revenue in 2022
    3.5 Combination Antibody Therapy Key Players Head office and Area Served
    3.6 Key Players Combination Antibody Therapy Product Solution and Service
    3.7 Date of Enter into Combination Antibody Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Combination Antibody Therapy Breakdown Data by Type
    4.1 Global Combination Antibody Therapy Historic Market Size by Type (2018-2023)
    4.2 Global Combination Antibody Therapy Forecasted Market Size by Type (2024-2029)
5 Combination Antibody Therapy Breakdown Data by Application
    5.1 Global Combination Antibody Therapy Historic Market Size by Application (2018-2023)
    5.2 Global Combination Antibody Therapy Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Combination Antibody Therapy Market Size (2018-2029)
    6.2 North America Combination Antibody Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Combination Antibody Therapy Market Size by Country (2018-2023)
    6.4 North America Combination Antibody Therapy Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Combination Antibody Therapy Market Size (2018-2029)
    7.2 Europe Combination Antibody Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Combination Antibody Therapy Market Size by Country (2018-2023)
    7.4 Europe Combination Antibody Therapy Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Combination Antibody Therapy Market Size (2018-2029)
    8.2 Asia-Pacific Combination Antibody Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Combination Antibody Therapy Market Size by Region (2018-2023)
    8.4 Asia-Pacific Combination Antibody Therapy Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Combination Antibody Therapy Market Size (2018-2029)
    9.2 Latin America Combination Antibody Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Combination Antibody Therapy Market Size by Country (2018-2023)
    9.4 Latin America Combination Antibody Therapy Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Combination Antibody Therapy Market Size (2018-2029)
    10.2 Middle East & Africa Combination Antibody Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Combination Antibody Therapy Market Size by Country (2018-2023)
    10.4 Middle East & Africa Combination Antibody Therapy Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Biogen
        11.1.1 Biogen Company Detail
        11.1.2 Biogen Business Overview
        11.1.3 Biogen Combination Antibody Therapy Introduction
        11.1.4 Biogen Revenue in Combination Antibody Therapy Business (2018-2023)
        11.1.5 Biogen Recent Development
    11.2 Roche Holdings
        11.2.1 Roche Holdings Company Detail
        11.2.2 Roche Holdings Business Overview
        11.2.3 Roche Holdings Combination Antibody Therapy Introduction
        11.2.4 Roche Holdings Revenue in Combination Antibody Therapy Business (2018-2023)
        11.2.5 Roche Holdings Recent Development
    11.3 Seattle Genetics
        11.3.1 Seattle Genetics Company Detail
        11.3.2 Seattle Genetics Business Overview
        11.3.3 Seattle Genetics Combination Antibody Therapy Introduction
        11.3.4 Seattle Genetics Revenue in Combination Antibody Therapy Business (2018-2023)
        11.3.5 Seattle Genetics Recent Development
    11.4 Amgen
        11.4.1 Amgen Company Detail
        11.4.2 Amgen Business Overview
        11.4.3 Amgen Combination Antibody Therapy Introduction
        11.4.4 Amgen Revenue in Combination Antibody Therapy Business (2018-2023)
        11.4.5 Amgen Recent Development
    11.5 Bristol-Myers Squibb
        11.5.1 Bristol-Myers Squibb Company Detail
        11.5.2 Bristol-Myers Squibb Business Overview
        11.5.3 Bristol-Myers Squibb Combination Antibody Therapy Introduction
        11.5.4 Bristol-Myers Squibb Revenue in Combination Antibody Therapy Business (2018-2023)
        11.5.5 Bristol-Myers Squibb Recent Development
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Detail
        11.6.2 Eli Lilly Business Overview
        11.6.3 Eli Lilly Combination Antibody Therapy Introduction
        11.6.4 Eli Lilly Revenue in Combination Antibody Therapy Business (2018-2023)
        11.6.5 Eli Lilly Recent Development
    11.7 Novartis
        11.7.1 Novartis Company Detail
        11.7.2 Novartis Business Overview
        11.7.3 Novartis Combination Antibody Therapy Introduction
        11.7.4 Novartis Revenue in Combination Antibody Therapy Business (2018-2023)
        11.7.5 Novartis Recent Development
    11.8 Sanofi
        11.8.1 Sanofi Company Detail
        11.8.2 Sanofi Business Overview
        11.8.3 Sanofi Combination Antibody Therapy Introduction
        11.8.4 Sanofi Revenue in Combination Antibody Therapy Business (2018-2023)
        11.8.5 Sanofi Recent Development
    11.9 Celgene
        11.9.1 Celgene Company Detail
        11.9.2 Celgene Business Overview
        11.9.3 Celgene Combination Antibody Therapy Introduction
        11.9.4 Celgene Revenue in Combination Antibody Therapy Business (2018-2023)
        11.9.5 Celgene Recent Development
    11.10 Genmab
        11.10.1 Genmab Company Detail
        11.10.2 Genmab Business Overview
        11.10.3 Genmab Combination Antibody Therapy Introduction
        11.10.4 Genmab Revenue in Combination Antibody Therapy Business (2018-2023)
        11.10.5 Genmab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Combination Antibody Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Chemotherapy Antibody
    Table 3. Key Players of Antibody
    Table 4. Key Players of Conjugated Antibodies
    Table 5. Key Players of Bispecific Antibodies
    Table 6. Global Combination Antibody Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Combination Antibody Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Combination Antibody Therapy Market Size by Region (2018-2023) & (US$ Million)
    Table 9. Global Combination Antibody Therapy Market Share by Region (2018-2023)
    Table 10. Global Combination Antibody Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 11. Global Combination Antibody Therapy Market Share by Region (2024-2029)
    Table 12. Combination Antibody Therapy Market Trends
    Table 13. Combination Antibody Therapy Market Drivers
    Table 14. Combination Antibody Therapy Market Challenges
    Table 15. Combination Antibody Therapy Market Restraints
    Table 16. Global Combination Antibody Therapy Revenue by Players (2018-2023) & (US$ Million)
    Table 17. Global Combination Antibody Therapy Market Share by Players (2018-2023)
    Table 18. Global Top Combination Antibody Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Combination Antibody Therapy as of 2022)
    Table 19. Ranking of Global Top Combination Antibody Therapy Companies by Revenue (US$ Million) in 2022
    Table 20. Global 5 Largest Players Market Share by Combination Antibody Therapy Revenue (CR5 and HHI) & (2018-2023)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Combination Antibody Therapy Product Solution and Service
    Table 23. Date of Enter into Combination Antibody Therapy Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Combination Antibody Therapy Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Global Combination Antibody Therapy Revenue Market Share by Type (2018-2023)
    Table 27. Global Combination Antibody Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 28. Global Combination Antibody Therapy Revenue Market Share by Type (2024-2029)
    Table 29. Global Combination Antibody Therapy Market Size by Application (2018-2023) & (US$ Million)
    Table 30. Global Combination Antibody Therapy Revenue Market Share by Application (2018-2023)
    Table 31. Global Combination Antibody Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 32. Global Combination Antibody Therapy Revenue Market Share by Application (2024-2029)
    Table 33. North America Combination Antibody Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 34. North America Combination Antibody Therapy Market Size by Country (2018-2023) & (US$ Million)
    Table 35. North America Combination Antibody Therapy Market Size by Country (2024-2029) & (US$ Million)
    Table 36. Europe Combination Antibody Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Europe Combination Antibody Therapy Market Size by Country (2018-2023) & (US$ Million)
    Table 38. Europe Combination Antibody Therapy Market Size by Country (2024-2029) & (US$ Million)
    Table 39. Asia-Pacific Combination Antibody Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 40. Asia-Pacific Combination Antibody Therapy Market Size by Region (2018-2023) & (US$ Million)
    Table 41. Asia-Pacific Combination Antibody Therapy Market Size by Region (2024-2029) & (US$ Million)
    Table 42. Latin America Combination Antibody Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. Latin America Combination Antibody Therapy Market Size by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Combination Antibody Therapy Market Size by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Combination Antibody Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 46. Middle East & Africa Combination Antibody Therapy Market Size by Country (2018-2023) & (US$ Million)
    Table 47. Middle East & Africa Combination Antibody Therapy Market Size by Country (2024-2029) & (US$ Million)
    Table 48. Biogen Company Detail
    Table 49. Biogen Business Overview
    Table 50. Biogen Combination Antibody Therapy Product
    Table 51. Biogen Revenue in Combination Antibody Therapy Business (2018-2023) & (US$ Million)
    Table 52. Biogen Recent Development
    Table 53. Roche Holdings Company Detail
    Table 54. Roche Holdings Business Overview
    Table 55. Roche Holdings Combination Antibody Therapy Product
    Table 56. Roche Holdings Revenue in Combination Antibody Therapy Business (2018-2023) & (US$ Million)
    Table 57. Roche Holdings Recent Development
    Table 58. Seattle Genetics Company Detail
    Table 59. Seattle Genetics Business Overview
    Table 60. Seattle Genetics Combination Antibody Therapy Product
    Table 61. Seattle Genetics Revenue in Combination Antibody Therapy Business (2018-2023) & (US$ Million)
    Table 62. Seattle Genetics Recent Development
    Table 63. Amgen Company Detail
    Table 64. Amgen Business Overview
    Table 65. Amgen Combination Antibody Therapy Product
    Table 66. Amgen Revenue in Combination Antibody Therapy Business (2018-2023) & (US$ Million)
    Table 67. Amgen Recent Development
    Table 68. Bristol-Myers Squibb Company Detail
    Table 69. Bristol-Myers Squibb Business Overview
    Table 70. Bristol-Myers Squibb Combination Antibody Therapy Product
    Table 71. Bristol-Myers Squibb Revenue in Combination Antibody Therapy Business (2018-2023) & (US$ Million)
    Table 72. Bristol-Myers Squibb Recent Development
    Table 73. Eli Lilly Company Detail
    Table 74. Eli Lilly Business Overview
    Table 75. Eli Lilly Combination Antibody Therapy Product
    Table 76. Eli Lilly Revenue in Combination Antibody Therapy Business (2018-2023) & (US$ Million)
    Table 77. Eli Lilly Recent Development
    Table 78. Novartis Company Detail
    Table 79. Novartis Business Overview
    Table 80. Novartis Combination Antibody Therapy Product
    Table 81. Novartis Revenue in Combination Antibody Therapy Business (2018-2023) & (US$ Million)
    Table 82. Novartis Recent Development
    Table 83. Sanofi Company Detail
    Table 84. Sanofi Business Overview
    Table 85. Sanofi Combination Antibody Therapy Product
    Table 86. Sanofi Revenue in Combination Antibody Therapy Business (2018-2023) & (US$ Million)
    Table 87. Sanofi Recent Development
    Table 88. Celgene Company Detail
    Table 89. Celgene Business Overview
    Table 90. Celgene Combination Antibody Therapy Product
    Table 91. Celgene Revenue in Combination Antibody Therapy Business (2018-2023) & (US$ Million)
    Table 92. Celgene Recent Development
    Table 93. Genmab Company Detail
    Table 94. Genmab Business Overview
    Table 95. Genmab Combination Antibody Therapy Product
    Table 96. Genmab Revenue in Combination Antibody Therapy Business (2018-2023) & (US$ Million)
    Table 97. Genmab Recent Development
    Table 98. Research Programs/Design for This Report
    Table 99. Key Data Information from Secondary Sources
    Table 100. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Combination Antibody Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Combination Antibody Therapy Market Share by Type: 2022 VS 2029
    Figure 3. Chemotherapy Antibody Features
    Figure 4. Antibody Features
    Figure 5. Conjugated Antibodies Features
    Figure 6. Bispecific Antibodies Features
    Figure 7. Global Combination Antibody Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Combination Antibody Therapy Market Share by Application: 2022 VS 2029
    Figure 9. Hospitals Case Studies
    Figure 10. Cancer Research Institutes Case Studies
    Figure 11. Clinics Case Studies
    Figure 12. ASCs Case Studies
    Figure 13. Combination Antibody Therapy Report Years Considered
    Figure 14. Global Combination Antibody Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 15. Global Combination Antibody Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Combination Antibody Therapy Market Share by Region: 2022 VS 2029
    Figure 17. Global Combination Antibody Therapy Market Share by Players in 2022
    Figure 18. Global Top Combination Antibody Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Combination Antibody Therapy as of 2022)
    Figure 19. The Top 10 and 5 Players Market Share by Combination Antibody Therapy Revenue in 2022
    Figure 20. North America Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. North America Combination Antibody Therapy Market Share by Country (2018-2029)
    Figure 22. United States Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Canada Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Combination Antibody Therapy Market Share by Country (2018-2029)
    Figure 26. Germany Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. France Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. U.K. Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Italy Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Russia Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Nordic Countries Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Combination Antibody Therapy Market Share by Region (2018-2029)
    Figure 34. China Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Japan Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. South Korea Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Southeast Asia Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. India Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Australia Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Combination Antibody Therapy Market Share by Country (2018-2029)
    Figure 42. Mexico Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Brazil Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Combination Antibody Therapy Market Share by Country (2018-2029)
    Figure 46. Turkey Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Saudi Arabia Combination Antibody Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Biogen Revenue Growth Rate in Combination Antibody Therapy Business (2018-2023)
    Figure 49. Roche Holdings Revenue Growth Rate in Combination Antibody Therapy Business (2018-2023)
    Figure 50. Seattle Genetics Revenue Growth Rate in Combination Antibody Therapy Business (2018-2023)
    Figure 51. Amgen Revenue Growth Rate in Combination Antibody Therapy Business (2018-2023)
    Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Combination Antibody Therapy Business (2018-2023)
    Figure 53. Eli Lilly Revenue Growth Rate in Combination Antibody Therapy Business (2018-2023)
    Figure 54. Novartis Revenue Growth Rate in Combination Antibody Therapy Business (2018-2023)
    Figure 55. Sanofi Revenue Growth Rate in Combination Antibody Therapy Business (2018-2023)
    Figure 56. Celgene Revenue Growth Rate in Combination Antibody Therapy Business (2018-2023)
    Figure 57. Genmab Revenue Growth Rate in Combination Antibody Therapy Business (2018-2023)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biogen
Roche Holdings
Seattle Genetics
Amgen
Bristol-Myers Squibb
Eli Lilly
Novartis
Sanofi
Celgene
Genmab
Frequently Asked Questions
Combination Antibody Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Combination Antibody Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Combination Antibody Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Combination Starters

This report aims to provide a comprehensive presentation of the global market for Combination Sta ... Read More

Combined Angiography

This report aims to provide a comprehensive presentation of the global market for Combined Angiog ... Read More